SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

NanoVibronix Inc

NAOV is trending following the grant of a new U.S. patent for its ENvue Medical subsidiary, which covers systems guiding medical device insertion using electromagnetic positioning. The community is discussing the stock's potential for further gains, consolidation patterns, and key price levels to watch, while also referencing the stock's low float and potential for a short squeeze.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is experiencing significant volatility, driven by speculation around a potential SOL treasury announcement. The community is actively discussing potential price targets and whether the stock is experiencing a pump and dump, while others highlight a possible incoming FDA submission. Some traders are comparing HSDT to other low float runners and weighing the potential for a short squeeze.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss the potential impact of a high short interest, the approaching launch of their digital wallet, and the proposed acquisition of Northern Data. Community members are actively debating the implications of these factors, particularly how they might lead to a short squeeze or significantly alter the company's valuation in the cloud computing and media landscape. Additionally, some traders are attributing increased attention to the stock following recent news and events involving prominent figures associated with the platform.

Lulu's Fashion Lounge Holdings, Inc. engages in providing an online website for clothing. It offers retailing of women's clothing, shoes, and accessories. The company was founded in 1996 and is headquartered in Chico, CA.

Lulus Fashion Lounge Holdings Inc

LVLU is trending due to recent price movement and community speculation about a potential short squeeze, driven by its ultra-low float and high short interest. Traders are actively discussing technical setups, analyst price targets, and comparing it to other low-float runners. Some are awaiting further catalysts, such as news or filings, to fuel further momentum.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

GLUE is trending due to a licensing agreement with Novartis potentially worth billions, leading to significant upfront payments and future royalties. Community members are debating whether to hold for long-term gains or take profits amidst discussions of short squeezes and potential price targets. The overall sentiment is bullish, driven by the news and the potential for substantial financial upside, though some caution against a possible pullback.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is trending as investors discuss potential short squeezes amidst high short interest and anticipation of upcoming Fed rate decisions. Community members are highlighting institutional accumulation and technical indicators suggesting a breakout. Recent positive analyst ratings and the company's strategic positioning in the mortgage and real estate market with acquisitions like Redfin are also fueling the conversation.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors assess its long-term potential following a recent dip, despite strong fundamentals and a monopoly in EUV lithography. Community discussions revolve around the impact of potential tariffs, the company's relationship with key players like Intel and TSMC, and its strategic role in the AI-driven semiconductor industry. Some analysts are pointing to an attractive entry point for the stock.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine ($APPS) is trending as investors digest news of a potential equity offering, leading to mixed reactions within the community. While some view it as a strategic move to reduce debt and strengthen the company's financial position, others express concern about potential dilution. Bullish sentiment remains, fueled by recent positive earnings and long-term growth prospects in the mobile advertising space.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid excitement surrounding its potential role in powering AI data centers and a new partnership with ABB, though some express concern about its high valuation and lack of revenue. Community discussions include potential price targets and comparisons to other nuclear companies, while others point to past news of share offerings as a cautionary sign. The stock's volatile price action is also a hot topic, with some traders looking to capitalize on short-term swings.

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.

AVITA Medical Inc

AVITA Medical (RCEL) is trending following the CE Mark approval for its RECELL GO device, allowing commercialization across Europe and markets recognizing the CE Mark; the community is discussing the expanded market reach and potential revenue growth. Some are highlighting real-world data showing reduced hospital stays and cost savings with RECELL, while others express concerns about cash flow and dilution. Bullish sentiment centers on the company's growth potential in the wound care market and possible takeover.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS  
its mostly irrelevant, as the true catalyst is the P3 readout- could be any day, and we’ll see something like $ABVX  
- everyone knew its p3 was due, it still gapped up 600% after a t1 halt and kept climbing.

bikechain

The Wolf of Finland

Michael Ryan

Hunt McKenzie

$SLS Hoping you can help me out.
Looking at timeline for GPS approval.
After we are approved ph3, then what?
Do we then lodge a BLA or NDA?
Then if approved we get a PDUFA date?
I know fast track or PRv could shorten timelines too. Any ideas on timeframe for commercial launch if SLS (hypothetically) were to walk that road? Any input is appreciated!
Cheers

StockTwits for iOS

SELLAS Life Sciences Group Inc

Klemmer777

$ABVX $SLS 

Thanks!

I’m fully aware my question is irrelevant with BP BO.

But that doesn’t answer my question.

My question was what is the timeline for GPS to commercial launch if SLS HYPOTHETICALLY   were to walk that road.
Cheers

StockTwits Web

Abivax - ADR

  
its mostly irrelevant, as the true catalyst is the P3 readout- could be any day, and we’ll see something like 

  
- everyone knew its p3 was due, it still gapped up 600% after a t1 halt and kept climbing.

GPs 24 / Control 8

@Gps_100X_ROI_Potential one day you will actually be right buddy! 

BUT Until that day, you are and will forever be a turd 💩   Hurry up and be right FFS so this “white trash, marks work warehouse suit wearing tin foil hat short scum” can cash in some chips! 

These couple hundred bucks penny flipping ain’t paying the bills